This course has expired. View available courses.
Oncology
Achieving long-term survival in BRAF mutation-positive melanoma in a rapidly-evolving therapeutic landscape – Certificate of Completion
DURATION
PROFESSION
Specialist
# OF CREDITS
2
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2019-03-31
Learning objectives
After completing this module, participants will be better able to:
- recall mechanisms of actions, indications, contra-indications, adverse effect (AE) profiles and Pharmaceutical Benefits Scheme (PBS) listing of novel targeted therapies for BRAF mutation-positive metastatic melanoma
- evaluate clinical trial evidence on efficacy and safety of each novel targeted therapy, including monotherapy and combination therapy
- discuss issues related to long-term survival: prognostic features, mutation type and resistance development
- monitor and manage adverse events related to novel therapies and optimise health-related quality of life (HRQoL)